This article reviews the recent literature on reward processing dysfunction in major depression (MDD), bipolar disorder and schizophrenia, with a focus on approach motivation, reward learning and rewardbased decision-making.
INTRODUCTION
In recent years, efforts focused on understanding reward-related dysfunction in psychiatric disorders have grown substantially. This has reflected the confluence of several currents, including significant preclinical advancements in understanding the neurobiology of approach-related behavior and a growing recognition that impairments in rewardrelated processes are insufficiently addressed by current treatments [1] . As a result, numerous studies have sought to test the presence of reward circuit dysfunction in clinical populations that exhibit alterations in motivation and/or hedonic responses. Moreover, as the field has increasingly eschewed categorical diagnostic boundaries in favor of symptom dimensions, there has been a parallel rise in studies seeking to identify transdiagnostic neural markers of reward processing dysfunction that may transcend disorders as distinct as major depressive disorder (MDD) and schizophrenia.
Central to this effort has been the recognition that 'reward processing' does not represent a unitary construct nor does it rely on a singular biological circuit. There are many distinct aspects subsumed under the term 'reward processing', including motivation, salience, anticipation, pleasure and satiety. In this critical review, we summarize recent advancements that support this transdiagnostic view of reward processing abnormalities in MDD, bipolar disorder and schizophrenia, and offer recommendations for future studies.
,4]. Critically, on prototypical tests of consummatory pleasure (e.g. the sweet taste test), individuals with MDD report normative ratings of hedonic responses [4] . In contrast, recent studies probing motivation, reinforcement learning and reward-based decision-making have uncovered a more nuanced understanding of reward processing dysfunction in MDD.
MDD, particularly in the presence of anhedonia, is characterized by a reduced ability to modulate behavior as a function of rewards [5 & ,6 ]. This reduction in reward responsiveness appears to persist after remission [7 & ] and has been found to predict MDD chronicity despite antidepressant treatment [5 & ]. Interestingly, reduced reward responsiveness has also been found in healthy participants following a pharmacologically induced attenuation of phasic dopaminergic signaling [6] . Collectively, these findings indicate that MDD is characterized by an inability to modulate behavior in response to intermittent rewards, possibly due to blunted phasic dopaminergic signaling critically implicated in reward learning.
In addition to reinforcement learning, dopamine has been strongly implicated in appetitive behaviors (e.g., reward anticipation) and effort-based rewardrelated decision-making. On the basis of mounting evidence of dopaminergic abnormalities in MDD [3 && ], one could expect that depressed individuals show blunted reward anticipation and willingness to exert effort in order to obtain rewards. Recent findings are consistent with these hypotheses. First, using the Effort Expenditure for Rewards Task (EEfRT or 'effort') -a task that requires individuals to choose between a potential low-effort, low-reward outcome vs. a high-effort, high-reward outcomeTreadway et al. [8] reported that individuals with MDD were less willing to exert physical effort to obtain potentially larger rewards. Relative to controls, MDD individuals also used information about reward magnitude and probability less effectively in order to guide their decisions [8] . Second, relative to healthy adolescents and adolescents with externalizing disorders, adolescents at an increased risk for depression (due to a family history of MDD) showed reduced reward seeking in a gambling task, the magnitude of which predicted depressive symptoms, MDD onset and diminished engagement in extracurricular activities 1 year later [9 & ].
In light of this behavioral evidence, and owing to preclinical data emphasizing the role of dopamine-rich mesocorticolimbic pathways (including ventral and dorsal striatal regions) in reinforcement learning, abnormalities in this circuitry might be hypothesized in MDD. Consistent with this notion, depressed adults showed reduced putamen activation during reward anticipation as well as reduced caudate, nucleus accumbens (NAcc) and dorsal anterior cingulate (ACC) activation to partially unpredictable rewards [10] . Recent findings indicate that ventral striatal blunting might constitute a risk factor for MDD. Specifically, reduced reward-related ventral striatal activation has been described in never-depressed youth at an increased risk for MDD due to a family history of MDD (e.g., [11]), is evident even when accounting for (subclinical) depressive symptoms [12 & ] and has been found to predict increases in depressive symptoms over 2 years among adolescents [13] . Furthermore, reduced feedback-related negativity (FRN) amplitude -an event-related potential (ERP) deflection thought to originate from reward prediction errorrelated activity in the dorsal ACC and striatal regions -predicted first-onset of MDD in a 2-year follow-up among never-depressed adolescent girls [14 & ].
Complementing these data are recent observations that reward-related striatal and cingulate abnormalities might be exacerbated by disease burden. Accordingly, during performance of an instrumental reinforcement task involving a selection of stimuli probabilistically linked to rewards, NAcc, ACC and ventromedial prefrontal cortex (vmPFC) activation during acquisition of reward
KEY POINTS
MDD is characterized by blunted processing of incentive salience, incentive motivation and reinforcement learning likely resulting from reduced phasic dopamine signaling, and these abnormalities are emerging as potential precursors of MDD.
Although there is strong evidence for the role of excessive dopamine bioavailability in BP (hypo)mania, these abnormalities may be state-dependent, and as a result, may not represent the primary pathophysiology of the disorder.
Research converges in support of a model of aberrant salience in schizophrenia, wherein excessive striatal dopamine release in response to meaningless or irrelevant stimuli may drive positive symptoms of psychosis, whereas an absence of dopamine firing critical for motivation may underpin negative symptoms of the disorder.
contingencies was greatest among healthy controls, intermediate in individuals facing their first major depressive episode (MDE) and lowest in individuals with recurrent MDD (> three prior MDEs and illness duration of at least 5 years) [15 & ].
In sum, when integrating these lines of evidence, it appears that blunted processing of incentive salience, incentive motivation and reinforcement learning (and associated NAcc and ACC hypoactivation) might be potent precursors of MDD. However, when these abnormalities are worsened by recurrences and emerge coupled with abnormalities in regions implicated in coding the hedonic value of stimuli (e.g. vmPFC), these disruptions might lead to more tenuous anticipatory reward-related associations, and ultimately anhedonic symptoms (see also [15 & ]).
BIPOLAR DISORDER: AN EMERGING PICTURE OF REWARD HYPERSENSITIVITY
A focus on the sequelae of dysfunction in rewardrelated dopamine signaling has given rise to the notion that (hypo)mania may in part result from a state of hyperdopaminergia. This theory was driven by early observations that dopamine agonists induce mania-like behavior in nonclinical individuals [16] , but compelling support has emerged from recent research showing that dopamine agonists exacerbate reward learning abnormalities -such as a preference for high-risk, high-reward choicesin euthymic individuals with bipolar disorder [17] .
Recent electrophysiological and neuroimaging studies corroborate this hypothesis, showing that (hypo)manic symptoms are associated with heightened reward-related activation in brain regions with high dopamine receptor density. An ERP study examining FRN deflection (an indirect index of prediction error-related dopamine signaling) to rewards of varying temporal proximity found that differences in FRN amplitude to immediate vs. delayed rewards was greater in hypomania-prone than in nonhypomania-prone individuals [18] . Similarly, evidence of abnormally elevated activity within the ventral striatum during reward anticipation [19 & ] and reward consumption [19 & ] has been found in depressed bipolar individuals, and to reward-predictive cues [20 & ] in euthymic bipolar individuals. A failure of prefrontal regions to effectively downregulate ventral striatal responses has also been observed [21] in a sample of euthymic to mildly depressed bipolar individuals, and regions that integrate reward-relevant information from limbic and prefrontal regions, such as the vmPFC, evidence a bias towards ventral striatal inputs [20 & ].
An important translational study suggests that increased dopamine bioavailability in bipolar disorder may arise due to depletions in dopamine transporter (DAT), which would result in increased dopamine levels. Thus, mice that have chronic or acute DAT depletion show increased rates of switching to high-risk, high-reward choices on the Iowa Gambling Task, similar to those observed individuals with bipolar disorder [22 && ]. This finding aligns with earlier evidence of lower DAT availability in the dorsal caudate of untreated individuals with bipolar disorder [23] , indicating that dopaminergic abnormalities in bipolar disorder may result from aberrant dopamine reuptake mechanisms.
Several key reward circuit abnormalities have also emerged that remain persistent in bipolar disorder across different mood states, and set it apart from MDD. First, heightened activation in the left ventrolateral PFC (vlPFC) during reward anticipation has been found in depressed bipolar disorder type I (BPI) individuals compared with controls and individuals with MDD [24 && ]. Left vlPFC activation has been associated with heightened arousal during processing of salient emotional stimuli [25] ; therefore, heightened activation in this region may reflect increased anticipation-related arousal in bipolar disorder during depressive episodes. Second, the effects of dopamine are mediated in part by their influence on glutamatergic (Glu) signals originating in the medial and vmPFC regions [26] , and two recent meta-analyses of studies using magnetic resonance spectroscopy found that individuals with MDD [27] and individuals with bipolar disorder [28] show decreased and increased levels of brain Glu, respectively. Importantly, increases in Glu or ratios of glutamate/glutamine have been found in bipolar disorder across states of mania [29] , depression [30] and euthymia [31] , indicating that glutamatergic abnormalities may contribute to trait-level differences in reward responding between bipolar disorder and MDD.
Possible differences in reward processing across the bipolar subtypes have also recently come to light. Self-report data have shown that BPI mania variability was associated with reward consumption and anticipation scores on the Behavioral Inhibition and Approach scales (BIS/BAS), whereas bipolar disorder type II (BPII) depression variability was associated with reward anticipation scores [32 & ]. A similar distinction was found in a recent imaging study showing that abnormalities in reward consumption-related activation were more prominent in BPI, whereas abnormalities in reward anticipation-related activation were more prominent in BPII [19 & ]. Given that anhedonia is most closely linked with abnormalities in reward anticipation rather than consumption (e.g., [33] ), a primarily anticipation-related impairment in BPII may explain the pervasiveness of depression in BPII relative to BPI.
Taken together, recent findings suggest that reward processing abnormalities in bipolar disorder may arise due to elevated activity within the dopamine-rich ventral striatum, and left vlPFC during reward processing. Although there is strong evidence for the role of excessive dopamine bioavailability in bipolar disorder, these abnormalities may be state-dependent, and therefore may not represent the primary pathophysiology of the disorder. Instead, abnormalities in levels of neurotransmitters that contribute to reward processing abnormalities across mood states, such as Glu, may represent a trait marker of bipolar disorder-related reward dysfunction.
SCHIZOPHRENIA: GROWING SUPPORT FOR THE 'ABERRANT SALIENCE' HYPOTHESIS
For over 50 years, dopamine circuitry has been postulated as a primary pathology in schizophrenia. The current iteration of the 'dopamine hypothesis' of schizophrenia [34] posits that positive and negative symptoms result from irregular (as opposed to enhanced or reduced) dopamine release that may ascribe 'aberrant salience' to irrelevant stimuli (resulting in positive symptoms) while failing to appropriately respond to meaningful reward cues (resulting in negative symptoms).
Supporting this hypothesis, a recent metaanalysis of PET studies using a dopamine precursor radioligand ([F 18 or C 11 ]-dopa) -an index of dopamine synthesis capacity -found that binding was substantially upregulated in psychosis [35] . In addition to this evidence for a global increase in striatal dopamine availability, functional MRI (fMRI) has been used to evaluate striatal responsivity during paradigms known to elicit dopamine burstfiring, such as trial-and-error learning. A number of imaging studies have highlighted associations between aberrant striatal responses and propensity for positive psychotic symptoms [34] . Most critically, recent work has demonstrated both a blunting of neural prediction errors to contextually relevant cues [36] and behavioral evidence for enhanced prediction error learning for irrelevant stimuli [37] . Collectively, these findings suggest that salience attribution mechanisms used to optimize the allocation of attentional resources are impaired in schizophrenia, and that such impairments are partially mediated by elevated striatal dopamine availability and altered striatal function.
Support for the aberrant salience model is also found in studies of negative symptoms in schizophrenia. Such symptoms typically involve reduced affective expression, decreased motivation and selfreported reductions in pleasurable experiences, and can be similar in clinical presentation to anhedonic and fatigue symptoms of MDD. Strikingly, despite self-reports of low positive affect and pleasurable experience on trait and symptom inventories, individuals with schizophrenia frequently show normative affective ratings in response to positively valenced laboratory stimuli [38] . This discordance between self-reported trait pleasure and momentary pleasure suggests that negative symptoms may not reflect a primary deficit in the capacity for hedonic experience, but rather a difficulty in representing rewarding experiences accurately [39] , a deficit that is consistent with disruptions in dopamine circuitry [40 & ].
To test this hypothesis, recent work in schizophrenia has examined effort-based decision-making, a process that is highly sensitive to striatal dopamine levels. In animals, blockade of striatal signaling via either dopamine receptor agonist or dopamine terminal lesions induce a behavioral shift away from larger or more preferred rewards that require extra effort to obtain [41] . On the basis of these studies, one might expect that negative symptoms in schizophrenia are associated with reduced striatal dopamine; however, this is contradicted by evidence for elevated striatal dopamine discussed above. Importantly, the aberrant salience hypothesis reconciles this apparent conflict with its prediction that individuals with schizophrenia should not necessarily exhibit less willingness to work than controls, but rather show deficient allocation of effort in terms of maximizing reward. Consistent with this hypothesis, three separate studies have found that individuals with schizophrenia did not exhibit an overall reduction in effort expenditure (as has been shown in individuals with MDD), but consistently failed to select the high effort option at times when it was most advantageous to do so [42, found that individuals with schizophrenia often failed to exert effort in pursuit of pleasurable activities, despite reporting that they anticipated enjoying the activities more than controls. These findings suggest that individuals with schizophrenia are unable to mobilize effort effectively, which is likely due to inadequate dopamine release to appropriate (high reward) trials.
In sum, recent evidence from behavioral paradigms, molecular imaging and fMRI studies converges in supporting a model of aberrant salience wherein excessive striatal dopamine release in response to meaningless or irrelevant stimuli may drive positive symptoms of psychosis. In contrast, blunted dopamine firing patterns critical for motivated responding to incentives may underpin negative symptoms of the disorder.
FUTURE DIRECTIONS: TRANSDIAGNOSTIC MECHANISM OR EQUIFINALITY
As summarized above, symptoms associated with altered reward processing share similar substrates across different disorders, supporting a transdiagnostic approach. On the basis of such evidence, it can be tempting to conclude that common pathological mechanisms must be at play. For instance, both MDD and schizophrenia are characterized by a reduced willingness to expend effort, both show blunted ventral striatal responses during reward anticipation and both show reduced prediction error signaling to rewards. Despite such similarities, it must be noted that there are many distinct pathological mechanisms that could result in alterations to striatal signaling (often referred to as 'equifinality'), and it is not necessarily the case that similar symptoms reflect similar diseases [46 & ]. Consequently, although transdiagnostic assessments may be valuable in identifying macrocircuits that need further investigation, similarities in neural responding during laboratory tasks should not outweigh the substantial differences in clinical presentation across these disorders. At their best, what symptom-focused transdiagnostic studies can provide is the opportunity to uncover new dimensions in symptom presentation that are not immediately evident to the clinically trained eye, but nevertheless possess reliable behavioral and neural correlates.
CONCLUSION
Reward processing abnormalities are central to the pathophysiology of MDD, bipolar disorder and schizophrenia, and mounting evidence points to cross-diagnostic dysfunction in reinforcement learning, effort-based reward-related decision-making and allocation of attention to reward-predictive cues. As transdiagnostic study designs increasingly compare distinct patient groups with common symptoms, the identification of shared and unique biological mechanisms will continue to improve, which is a prerequisite step toward the development of improved prevention and treatment strategies. This study shows that low levels of reward-seeking are present even prior to the onset of depression, and beyond depression severity, are related to levels of social engagement in daily life. These findings highlight reward-learning deficits as both a risk and a maintaining factor of depression. 
